Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy.

Ying M, Fan Z, He Y, Qi M, Dong B, Lu A, Li J, Xie Y, Wang T, Lin B, Ouyang T.

Open source

DOI
10.21873/invivo.14452
Published
2026-09-01
Container
In Vivo
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14452,
  title = {Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy.},
  author = {Ying M and  Fan Z and  He Y and  Qi M and  Dong B and  Lu A and  Li J and  Xie Y and  Wang T and  Lin B and  Ouyang T.},
  year = {2026},
  journal = {In Vivo},
  doi = {10.21873/invivo.14452},
  url = {https://doi.org/10.21873/invivo.14452}
}

RIS

TY  - JOUR
TI  - Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy.
AU  - Ying M
AU  -  Fan Z
AU  -  He Y
AU  -  Qi M
AU  -  Dong B
AU  -  Lu A
AU  -  Li J
AU  -  Xie Y
AU  -  Wang T
AU  -  Lin B
AU  -  Ouyang T.
PY  - 2026
JO  - In Vivo
DO  - 10.21873/invivo.14452
UR  - https://doi.org/10.21873/invivo.14452
ER  - 

APA

M, Y., Z, F., Y, H., M, Q., B, D., A, L., J, L., Y, X., T, W., B, L., & T., O. (2026). Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy.. In Vivo. https://doi.org/10.21873/invivo.14452

Source records